KT&G Subsidiary Faces Facility Investment Dilemma as Capacity Expansion Outpaces Weak Order Demand

Jul.15
KT&G Subsidiary Faces Facility Investment Dilemma as Capacity Expansion Outpaces Weak Order Demand
KT&G subsidiary Taeya Industry booked heavy impairment losses after overinvesting in capacity based on inaccurate demand forecasts. Although KT&G aims to offset the damage through global value-chain expansion, Taeya’s financial health remains severely strained, and the company is now devising new export programs to utilize its idle facilities.

Key points: 

 

- Facility investment dilemma: KT&G subsidiary Taeya Industry (core raw material supplier for KT&G cigarettes and heated tobacco products) suffered from overcapacity due to inaccurate demand forecasting, resulting in a net loss of approximately $26.9 million last year.

 

- Expansion and challenges: Despite expanding capacity since 2004, new facilities were unable to be fully utilized due to shrinking domestic tobacco demand and anti-smoking policies. 

 

- Sales growth: By increasing cigarette leaf prices, sales are projected to increase from $19.15 million in 2021 to $30.09 million in 2024, maintaining a 2% to 3% operating profit margin. 

 

- Future plans: KT&G plans to export Taeya Industry's cigarette leaves overseas to drive global expansion, with expected impairment losses being offset as production volumes increase.

 


 

【2Firsts News Flash】According to reports from Korean media, KT&G's subsidiary, Taeya Industry, is facing difficulties in facility investments due to failed demand forecasting. The company expanded its cigarette leaf production facilities with funding from its parent company, KT&G, but the inadequate demand led to significant asset impairment losses and impacted financial stability. Last year, Taeya Industry's net loss reached 35.4 billion Korean won (approximately $26.9 million).

 

Taeyang Industries is the core raw material supplier for KT&G cigarettes and heated tobacco products. The products are currently produced at factories in Daegu and Gimcheon and are all supplied to KT&G.

 

Since being acquired by KT&G in 2004, Taeyang Industries has continued to expand its production capacity and secure raw material supply. In 2018 and 2022, Taeyang Industries purchased production equipment from KT&G and expanded its capacity. However, forecasting errors in demand led to a 36 billion Korean Won asset impairment loss, including 13.6 billion Korean Won (approximately $10.33 million) in machinery and 22.4 billion Korean Won (approximately $17.02 million) in construction in progress assets, resulting in some new facilities being idle.

 

The domestic tobacco market demand is shrinking, coupled with the rise of health awareness and the government's promotion of anti-smoking policies, leading to the Taeyang industry facing difficulties. In 2024, KT&G's domestic cigarette sales are expected to decline, and factory operating rates are also declining.

 

However, Taeya Industries has managed to deal with the difficulties by increasing the price of tobacco leaves, leading to a growth in sales each year. From 2021 to 2024, Taeya Industries' sales increased from 25.2 billion Korean won (approximately 19.15 million US dollars) to 39.6 billion Korean won (approximately $30.09 million), maintaining a profit margin of 2% to 3%.

 

In order to utilize its new facilities, KT&G plans to export the tobacco leaves produced by Thaiya Industries overseas. By constructing and expanding overseas factories, Thaiya Industries will actively promote global business expansion. It is expected that as global production increases, depreciation losses will be recovered in the future.

 

KT&G stated that the expansion of its Taeyoung Industries' facilities is being done in preparation for future demand and added that the losses from asset impairment will gradually recover as production capacity increases.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai
KT&G Collaborates with Beauty Brand Hotel Dawson to Launch Limited Edition Heated Tobacco “Lil Hybrid 3.0”
KT&G Collaborates with Beauty Brand Hotel Dawson to Launch Limited Edition Heated Tobacco “Lil Hybrid 3.0”
KT&G has partnered with South Korean beauty and lifestyle brand Hotel Dawson to jointly launch the heated tobacco product “Lil Hybrid 3.0,” which will be available across multiple sales platforms.
Jul.21 by 2FIRSTS.ai
BAT Challenges Polish Tax Authorities as 200,000 Pods Seized, Potential Loss Exceeds $2.7 Million
BAT Challenges Polish Tax Authorities as 200,000 Pods Seized, Potential Loss Exceeds $2.7 Million
British American Tobacco (BAT) strongly disputes the Polish tax authority’s seizure of over 200,000 e-cigarette pods imported by its partner, citing lack of legal basis and possible unlawful expropriation. Despite plans for legal sale before new tax rates, the goods were confiscated. BAT estimates losses above PLN 10 million ($2.77 million) and may pursue legal action domestically and internationally.
Jul.18 by 2FIRSTS.ai
Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%
Australian Government-Funded Vaping Education Program Featured in The Lancet: Student Vaping Rates Drop by 65%
Australia’s “OurFutures” vaping education program cut student vaping rates by 65% after 12 months, according to a trial of 5,000 students across 40 schools. Published in The Lancet, it is the first proven effective school-based e-health intervention in Australia. The program will be expanded through 2028, with long-term data expected in 2026.
Jul.29 by 2FIRSTS.ai
Product | OXBAR's new "Three-warehouse, Three-control" design with sweetness, coolness, and nicotine adjustment enters EU/US markets.
Product | OXBAR's new "Three-warehouse, Three-control" design with sweetness, coolness, and nicotine adjustment enters EU/US markets.
The new OXBAR e-cigarette TRI-FUSION has recently been launched on the official website. The product features three independent buttons that allow for the adjustment of sweetness, nicotine concentration, and coolness separately, and claims to offer 100 flavor combinations. Currently, the product is available on retail websites in the United States, the United Kingdom, and Canada.
Aug.29 by 2FIRSTS.ai
PMI Launches IQOS ILUMA i Series in Saudi Arabia to Support a Smoke-Free Future
PMI Launches IQOS ILUMA i Series in Saudi Arabia to Support a Smoke-Free Future
Philip Morris International (PMI) has launched its next-generation heated tobacco products, the IQOS ILUMA i series, in Saudi Arabia, debuting with two devices: ILUMA i PRIME and ILUMA i.
Jul.09 by 2FIRSTS.ai